---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "WpddAHvAmgCtU8+Qe2V3V0iRGaWSCLwWO9OvxtCtmBIZcvyj+fKzpDJipuDmeHb8ALgomIH2IA6vMGOxKonr6laEN7+M8yAvyRFcm33aMVyB6skuVkWQO0rrF6TmeSn9LmWqbLLrv8i2Fzz1/683Lc97iGYLLda2OLH3H8gnaFSZDPJh6ux2IOVypTPsrviofNXSuVa1S2RQFU9q71hI7rxCcnTe1mLZphqe8IQmc25aSx60T5RKUX9na2ZSTqQgYEnWYKbBCj9F3M4rDWVx2Z4pPFaGXKNPM/uu3N65dmANkRKjw0DS15ga3hPIi1JN9mCmetUI/OCh4QhM0UMfX+uQ31m6h2QmiJRY966KLMM=;pOvMb/8pUVvJycqwMBji2g=="
---

